AKT1 and breast carcinoma: Intriguingly, Srinivasan et al. stated that diosgenin processed chemotherapeutic effects through targeting Akt-mediated NF-κB and MAPK (prosurvival) signaling in human breast carcinoma (BCa) cells [49].